Hematology/Oncology

Top Story

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy
February 12, 2016

Black women appeared less likely than those from other racial backgrounds to benefit from neoadjuvant chemotherapy, according to results of a database study.

In addition, black women appeared less likely to achieve pathologic complete response for triple-negative or HER-2–positive breast cancer.

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

February 12, 2016
The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national…

Lung cancer expert named to NCI board

February 12, 2016
Roman Perez-Soler, MD, chairman and chief of the department of oncology at Montefiore Einstein Center for Cancer Care, has been named to NCI’s board of scientific…
In the Journals

Pretransplant melanoma associated with melanoma, mortality after transplant

February 12, 2016
Researchers found an association between pretransplant melanoma and increased melanoma-specific mortality, overall mortality and incident melanoma after transplant…
In the Journals

IV pegylated asparaginase shows promise for pediatric ALL

February 12, 2016
IV pegylated asparaginase yielded similar efficacy as intramuscular native Escherichia coli L-asparaginase without increasing toxicity in pediatric patients with newly…
More News Headlines »
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video

VIDEO: Microsatellite instability predicts enhanced response to immunotherapy

February 4, 2016
More »
Featured
CME

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan